We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-0.98%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$6.93B
AUM Growth
+$138M
Cap. Flow
+$286M
Cap. Flow %
4.13%
Top 10 Hldgs %
15.14%
Holding
1,219
New
309
Increased
239
Reduced
256
Closed
371

Sector Composition

Rank Sector Weight
1 Healthcare 16.02%
2 Technology 12.55%
3 Financials 11.58%
4 Communication Services 10.85%
5 Consumer Discretionary 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDW icon
26
CDW
CDW
$17.1B
$49M 0.71%
1,576,844
+1,108,564
+237% +$35M
COF icon
27
Capital One
COF
$124B
$48.5M 0.7%
594,611
+484,277
+439% +$39.6M
C icon
28
Citigroup
C
$222B
$47.1M 0.68%
908,266
+291,654
+47% +$14.7M
GILD icon
29
Gilead Sciences
GILD
$161B
$46.9M 0.68%
440,767
+327,344
+289% +$32.1M
EVHC
30
DELISTED
Envision Healthcare Holdings Inc
EVHC
$46.4M 0.67%
+447,107
New +$47.4M
UNP icon
31
Union Pacific
UNP
$183B
$46.3M 0.67%
426,878
-340,280
-44% -$35.2M
CP icon
32
Canadian Pacific Kansas City
CP
$82B
$45.1M 0.65%
1,086,890
-827,585
-43% -$32.4M
SXT icon
33
Sensient Technologies
SXT
$5.4B
$44.5M 0.64%
850,739
-91,353
-10% -$4.98M
HSY icon
34
Hershey
HSY
$35.4B
$43.5M 0.63%
455,999
-209,489
-31% -$19.4M
PFE icon
35
Pfizer
PFE
$140B
$43.3M 0.63%
1,544,672
+1,164,995
+307% +$32.7M
SNDK
36
DELISTED
SANDISK CORP
SNDK
$42.4M 0.61%
433,077
+99,706
+30% +$9.75M
CELG
37
DELISTED
Celgene Corp
CELG
$41.7M 0.6%
439,599
+6,478
+1% +$585K
LBTYA icon
38
Liberty Global Class A
LBTYA
$3.31B
$41.1M 0.59%
1,172,540
-608,875
-34% -$21.7M
BHI
39
DELISTED
Baker Hughes
BHI
$40.5M 0.58%
622,361
+475,932
+325% +$33.2M
RF icon
40
Regions Financial
RF
$26.3B
$40.1M 0.58%
3,991,300
+2,767,356
+226% +$28.2M
AMGN icon
41
Amgen
AMGN
$203B
$36.9M 0.53%
262,519
+190,553
+265% +$24.9M
PARA
42
DELISTED
Paramount Global Class B
PARA
$36.5M 0.53%
681,348
+111,957
+20% +$6.59M
ALXN
43
DELISTED
Alexion Pharmaceuticals
ALXN
$35.8M 0.52%
215,684
+162,413
+305% +$26.7M
LAZ icon
44
Lazard
LAZ
$4.37B
$34.8M 0.5%
687,261
-777,962
-53% -$40.8M
IFF icon
45
International Flavors & Fragrances
IFF
$19.4B
$34.4M 0.5%
359,240
+24,712
+7% +$2.5M
AXP icon
46
American Express
AXP
$223B
$34M 0.49%
387,862
+314,384
+428% +$28.3M
QIWI
47
DELISTED
QIWI PLC
QIWI
$32.6M 0.47%
1,030,963
+153,184
+17% +$5.73M
JNPR
48
DELISTED
Juniper Networks
JNPR
$32.4M 0.47%
1,462,123
+1,314,325
+889% +$30.8M
PF
49
DELISTED
Pinnacle Foods, Inc.
PF
$31.9M 0.46%
+978,436
New +$31M
BCR
50
DELISTED
CR Bard Inc.
BCR
$31.6M 0.46%
221,597
-45,335
-17% -$6.7M

Similar funds

Marshall Wace's Q3 2014 Portfolio in Review

As of Q3 2014, Marshall Wace held 1,219 positions worth $6.93B, up 2% from $6.79B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Marshall Wace deployed $286M of net new capital in Q3 2014, opening 309 new positions and adding to 239 existing holdings. Its largest new stake was Alibaba: 879,212 shares worth $78.1M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Baidu, an estimated $70.9M trimmed.

  • Marshall Wace's largest Q3 2014 buy was Alibaba: 879,212 shares worth $78.1M.
  • Marshall Wace added most to WisdomTree India Earnings Fund ETF in Q3 2014, an estimated $114M increase.
  • Marshall Wace's biggest Q3 2014 reduction was Baidu, cutting an estimated $70.9M.
  • Marshall Wace fully exited Herc Holdings in Q3 2014, selling an estimated $39.3M.
  • Marshall Wace's ten largest holdings make up 15% of its $6.93B portfolio in Q3 2014.
  • Marshall Wace opened 309 new positions and closed 371 in Q3 2014.
  • Marshall Wace's portfolio value rose 2% quarter-over-quarter to $6.93B.

Based on Marshall Wace's 13F filing for Q3 2014, filed 13 Nov 2014.